| RS2141138370 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS2141138391 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS2141138396 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS2141138493 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141138753 |
CLN6
|
Health Risk |
Likely pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS2141138964 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141139300 |
CLN6
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Ceroid lipofuscinosis |
| RS2141140456 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2141141420 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141141525 |
CLN6
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2141141533 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS2141143799 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141143881 |
DUOX2
|
Health Risk |
Likely pathogenic |
Congenital hypothyroidism, Congenital hypothyroidism |
| RS2141144285 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2141144931 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141145023 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141145071 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141145074 |
CLN6
|
Health Risk |
Pathogenic |
— |
| RS2141145116 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141145188 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141145828 |
DUOX2
|
Health Risk |
Pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2141146617 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141147087 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141147450 |
AP4E1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 51 |
| RS2141147698 |
PACS2
|
Health Risk |
Likely pathogenic |
— |
| RS2141148172 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141150691 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141150812 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2141151209 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141151636 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141153735 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141153740 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2141155132 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS2141155238 |
IGF1R
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2141156157 |
CLN6
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2141156206 |
USP7
|
Health Risk |
Likely pathogenic |
— |
| RS2141160202 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2141160425 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141160443 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141160513 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141160577 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS2141160881 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141161066 |
PRIMA1
|
Health Risk |
Pathogenic |
Familial sleep-related hypermotor epilepsy, Familial sleep-related hypermotor epilepsy |
| RS2141163058 |
RALGAPA1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency |
| RS2141163549 |
RALGAPA1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency |
| RS2141164712 |
AP4E1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2141164715 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy |
| RS2141164830 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141164878 |
AP4E1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 51, Spastic paraplegia |
| RS2141167019 |
USP7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, Hao-Fountain syndrome |
| RS2141167797 |
CAPN3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2141167851 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS2141168796 |
LRRK1
|
Health Risk |
Pathogenic |
Osteosclerotic metaphyseal dysplasia, Osteosclerotic metaphyseal dysplasia |
| RS2141169116 |
NR2F2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2141169336 |
NR2F2
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS2141170197 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141170209 |
MIR184
|
Health Risk |
Pathogenic |
EDICT syndrome, EDICT syndrome |
| RS2141170517 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141171226 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2141172134 |
IFT140
|
Health Risk |
Pathogenic |
Retinal dystrophy, Saldino-Mainzer syndrome |
| RS2141172226 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS2141176797 |
CAPN3
|
Health Risk |
Pathogenic |
Muscular dystrophy, limb-girdle |
| RS2141176978 |
CAPN3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2141176996 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141177054 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141179932 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS2141180025 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2141181339 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2141181367 |
GNB5
|
Health Risk |
Pathogenic |
Gnb5-related intellectual disability-cardiac arrhythmia syndrome, Gnb5-related intellectual disability-cardiac arrhythmia syndrome |
| RS2141185231 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS2141185978 |
USP7
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2141186036 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2141190525 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2141193077 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2141193533 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS2141193854 |
GNB5
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the nervous system, Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia |
| RS2141194090 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS2141194911 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2141194926 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2141197839 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2141198335 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS2141199028 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2141199370 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141199590 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2141199638 |
CAPN3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2141199686 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141199752 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS2141199913 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS2141199970 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141200280 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2141200474 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2141200617 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2141202384 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2141202895 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2141202919 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141202964 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2141203052 |
CAPN3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2141203402 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2141203435 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141204933 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |